← Open Payments lookup

EMMANUEL MAKIA: Open Payments

NPI 1942866801 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$432 in 20 payments from 5 companies in 2025. Trend: 2023 $1,212 · 2024 $488 · 2025 $432

Food & beverage: $432
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$192
Neurocrine BioSciences, Inc.5$155
Teva Pharmaceuticals USA, Inc.2$45
E.R. Squibb & Sons, L.L.C.1$22
ACADIA Pharmaceuticals Inc1$18

Products named: REXULTI, INGREZZA, AUSTEDO XR, COBENFY, NUPLAZID.

Industry payments across TX — which companies pay providers there.